ArticleScientific reports2025
Benchmarking of dimensionality reduction methods to capture drug response in transcriptome data.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Drug-induced transcriptomic data are crucial for understanding molecular mechanisms of action (MOAs), predicting drug efficacy, and identifying off-target effects. However, their high dimensionality presents challenges for analysis and interpretation. Dimensionality reduction (DR) methods simplify such data, enabling efficient analysis and visualization. Despite their importance, few studies have evaluated the performance of DR methods specifically for drug-induced transcriptomic data. We tested the DR methods across four distinct experimental conditions using data from the Connectivity Map (CMap) dataset, which includes different cell lines, drugs, MOA, and drug dosages. t-distributed Stochastic Neighbor Embedding (t-SNE), Uniform Manifold Approximation and Projection (UMAP), Pairwise Controlled Manifold Approximation (PaCMAP), and TRIMAP outperformed other methods in preserving both local and global biological structures, particularly in separating distinct drug responses and grouping drugs with similar molecular targets. However, most methods struggled with detecting subtle dose-dependent transcriptomic changes, where Spectral, Potential of Heat-diffusion for Affinity-based Trajectory Embedding (PHATE), and t-SNE showed stronger performance. Standard parameter settings limited the optimal performance of DR methods, highlighting the need for further exploration of hyperparameter optimization. Our study provides valuable insights into the strengths and limitations of various DR methods for analyzing drug-induced transcriptomic data. While t-SNE, UMAP, and PaCMAP are well-suited for studying discrete drug responses, further refinement is needed for detecting subtle dose-dependent changes. This study highlights the importance of selecting the DR method to accurately analyze drug-induced transcriptomic data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.